| Abstrakt: |
A recent study conducted at Tianjin University in the People's Republic of China focused on the development of RALA-derived peptides for efficient gene delivery in siRNA-based therapy. The research highlighted the effectiveness of three modified peptides in encapsulating, releasing, and uptaking nucleic acids, with high transfection efficiency and silencing rates. The study concluded that these peptides show promise as powerful carriers for siRNA therapy in treating various diseases. The research has been peer-reviewed and offers potential applications in the field of gene therapy. [Extracted from the article] |
